摘要
肝癌患者的治疗效果不佳,生存期不长。合并癌栓是进行肝癌临床分期、选择治疗方法、评估预后等方面的重要参考指标。原发性肝癌合并门静脉癌栓的治疗方法众多,主要包括外科手术、介入治疗、放射治疗、分子靶向治疗及系统化疗等。目前多学科治疗(MDT)开展综合治疗是趋势,也是提高疗效的途径及发展方向。最近,国内首个肝癌门静脉癌栓多学科诊治达成中国专家共识,将为肝癌门静脉癌栓患者的诊断治疗提供指导性意见推动我国肝癌诊治水平的不断提高。
The treatment of patients with primary liver cancer was poor survival was not long. Merge tumor thrombus is important reference index to determine clinical stage,choose treatment and evaluate prognosis of primary liver cancer. The treatment methods of primary liver cancer with portal vein tumor thrombus are numerous,including surgery,interventional therapy,radiotherapy,chemotherapy and molecular target therapy system. The multi- disciplinary treatment（ MDT） to carry out comprehensive treatment is a trend,is also a way to improve the function and development direction. Recently,the first multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus in China has reached expert consensus,will provide diagnosis and treatment guidance for primary liver cancer patients with portal vein tumor thrombus.
作者
杨晓辉
彭焱
Yang Xiaohui Peng Yan(Departement of Oncology Departement of Internal Medicine, The Liuzhou Steel Group＇s Hospital, Guangxi Liuzhou 545002, China.)
出处
《现代肿瘤医学》
CAS
2016年第23期3863-3867,共5页
Journal of Modern Oncology
关键词
原发性肝癌
门静脉癌栓
治疗
primary liver cancer
portal vein tumor thrombus
treatment
